Literature DB >> 10536312

Site specificity of colorectal neoplasms in families without an inherited syndrome.

P Zauber1, G Lardieri, P J Rathouz, N Khan, D T Bishop.   

Abstract

BACKGROUND: Relatives of patients with bowel neoplasia have an increased risk of bowel neoplasia. If there were concordance in location of neoplasia between relatives, then location-specific screening could be used. Such concordance might also assist in the understanding of the etiology of neoplasia within individual families.
METHODS: We have investigated the concordance in anatomic location of colonic neoplasia between first-degree relatives using a new statistical technique for paired data called alternating logistic regression.
RESULTS: A total of 146 families were ascertained, none of which had clinical evidence of a hereditary predisposition to edon neoplasia. Among those with neoplasia, there was an increased risk for right-sided disease with older age (40% for less than age 60 vs. 58% for at least 70 years of age, p = 0.008). As assessed by the odds ratio, we found no significant concordance within families for location of neoplasia (odds ratio = 1.2: CI [0.7, 2.2]), although there was a suggestion that location in family members of the same generation was more strongly associated (odds ratio 1.87: CI [0.82, 4.25]).
CONCLUSIONS: The lack of concordance within families for location argues against considering family-specific bowel screening protocols and indicates that the most important causes of bowel neoplasia are not sufficiently focused on one anatomic site to facilitate etiologic research.

Entities:  

Mesh:

Year:  1999        PMID: 10536312     DOI: 10.1016/s0016-5107(99)80005-4

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  1 in total

1.  Estimation of the familial relative risk of cancer by site from a French population based family study on colorectal cancer (CCREF study).

Authors:  N Andrieu; G Launoy; R Guillois; C Ory-Paoletti; M Gignoux
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.